Project Description
Updates from the CBTP Lab
The lab team at the Children’s Brain Tumor Project is working at an unprecedented pace in order to advance cures. Our team is focused on two strategic paths forward: (1) basic research toward breakthrough discoveries, and (2) translational research that will enable us to bring those discoveries to clinic.
Navigating the COVID-19 Pandemic
A message from our founders on the global health crisis and how it is impacting the Children's Brain Tumor Project.
Record-Breaking Donation for DIPG
November 30, 2021 - John Rivera presents a $300,000 check on behalf of the Cristian Rivera Foundation to Dr. Mark Souweidane in support of DIPG research. The surprise donation was appropriately made at the end of the day on Giving Tuesday, 2021.
Light up the Lab 2021
As 2021 comes to a close, we’re asking all of our supporters to remember those children who they hold so close to their hearts, and to help us light up the lab by paying tribute to them with a year-end, tax-deductible contribution.
The Michels Family Endowment
DECEMBER 20, 2020 - Inspired by their daughter's diagnosis with choroid plexus carcinoma, the Michels Family has awarded Dr. Mark Souweidane with an endowed fund for pediatric neurological surgery.
Dr. Souweidane Contributes to Manuscript on Germ Cell Tumors
Nov 1, 2021 - Dr. Mark Souweidane contributed to a peer-reviewed article on intracranial germ cell tumors published in Neurooncology.
JNS Pediatrics August 2021
Aug 17, 2021 - Designing new routes of administration for drugs to inoperable brain tumors is central to the mission of the Children’s Brain Tumor Project. A major advance forward in these efforts was recently published from Dr. Greenfield’s group in the August issue of Journal of Neurosurgery: Pediatrics.
Dr. Souweidane Presents at ASCO 2021
June 4, 2021 - Dr. Mark Souweidane, in partnership with Y-mAbs Therapeutics, presented interim phase 1 dose-escalation data for omburtamab for DIPG at virtual ASCO conference.